The Japanese equity market has been on an impressive run over the past month, with the Nikkei Stock Average rising to its highest level in nearly three decades.
A factor behind the Japanese market's gains, and those of the global markets as a whole, has been expectations of the development and rollout of Covid-19 vaccines. Hopes for government stimulus also gave the market an extra boost. In addition, expectations that non-contact business segments (such as teleconferencing and medical treatment providers) would enjoy growth in a "new normal" brought about by the pandemic have also supported the market. Suganomics is coming to Japan - and it wants to unleash a digital revolution While the aforementioned factors have certainly helpe...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
